Cite
HARVARD Citation
Di Liello, R. et al. (2021). Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. International journal of gynecological cancer. 31 (10), pp. 1348-1355. [Online].